ABT
Abbott Laboratories
$95.84
+0.21 (+0.22%)
At close · Jul 7
Market Cap
$166.94B
Shares
1,741,812,429
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-04-29 | 2026-03-31 | |
| 8-K | 2026-04-27 | 2026-04-24 | |
| 8-K | 2026-04-17 | 2026-04-10 | |
| 8-K | 2026-04-16 | — | |
| 8-K | 2026-03-23 | — | |
| DEF 14A | 2026-03-13 | 2026-04-24 | |
| 8-K | 2026-03-09 | — | |
| 8-K | 2026-02-26 | 2026-02-23 | |
| 8-K | 2026-02-20 | — | |
| 10-K | 2026-02-20 | 2025-12-31 | |
| 8-K | 2026-01-22 | — | |
| 8-K | 2025-12-12 | — | |
| 8-K | 2025-11-21 | 2025-11-18 | |
| 8-K | 2025-11-20 | 2025-11-19 | |
| 10-Q | 2025-10-29 | 2025-09-30 | |
| 8-K | 2025-10-15 | — | |
| 10-Q | 2025-07-30 | 2025-06-30 | |
| 8-K | 2025-07-17 | — | |
| 8-K | 2025-05-01 | 2025-04-25 | |
| 10-Q | 2025-04-30 | 2025-03-31 | |
| 8-K | 2025-04-28 | 2025-04-25 | |
| 8-K | 2025-04-16 | — | |
| DEF 14A | 2025-03-14 | 2025-04-25 | |
| 10-K | 2025-02-21 | 2024-12-31 | |
| 8-K | 2025-01-22 | — | |
| 8-K | 2024-11-15 | 2024-11-12 | |
| 10-Q | 2024-10-31 | 2024-09-30 | |
| 8-K | 2024-10-16 | — | |
| 10-Q | 2024-07-31 | 2024-06-30 | |
| 8-K | 2024-07-18 | — | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| 8-K | 2024-05-01 | 2024-04-26 | |
| 8-K | 2024-04-29 | 2024-04-26 | |
| 8-K | 2024-04-17 | — | |
| DEF 14A | 2024-03-15 | 2024-04-26 | |
| 10-K | 2024-02-16 | 2023-12-31 | |
| 8-K | 2024-01-29 | — | |
| 8-K | 2024-01-24 | — | |
| 10-Q | 2023-11-01 | 2023-09-30 | |
| 8-K | 2023-10-18 | — | |
| 8-K/A | 2023-09-01 | 2023-04-28 | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-07-20 | — | |
| 8-K | 2023-06-12 | 2023-06-09 | |
| 8-K/A | 2023-06-09 | 2023-04-28 | |
| 10-Q | 2023-05-04 | 2023-03-31 | |
| 8-K | 2023-05-02 | 2023-04-28 | |
| 8-K | 2023-04-19 | — | |
| DEF 14A | 2023-03-17 | 0001-01-01 | |
| 8-K | 2023-02-17 | — |
Showing 1–50 of 98 filings